134 related articles for article (PubMed ID: 3317854)
1. Prognostic and therapeutic advances in CLL management: the experience of the French Cooperative Group. French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Hematol; 1987 Oct; 24(4):275-90. PubMed ID: 3317854
[No Abstract] [Full Text] [Related]
2. Staging of chronic lymphocytic leukemia by total tumor mass (TTM) score. Evaluation of 121 patients.
Brugiatelli M; Morabito F; Restifo D; Neri A
Haematologica; 1985; 70(5):405-13. PubMed ID: 3937776
[No Abstract] [Full Text] [Related]
3. Patient accrual and interim statistical analysis in long-term randomized clinical trials: the French chronic lymphocytic leukemia CLL 80 protocol as a case study.
Chastang C; Travade P; Benichou J; Dighiero G; Binet JL
Stat Med; 1986; 5(5):465-73. PubMed ID: 3538262
[TBL] [Abstract][Full Text] [Related]
4. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
Binet JL
Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
[No Abstract] [Full Text] [Related]
5. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
[TBL] [Abstract][Full Text] [Related]
6. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
[TBL] [Abstract][Full Text] [Related]
7. Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisone.
Montserrat E; Alcalá A; Parody R; Domingo A; García-Conde J; Bueno J; Ferrán C; Sanz MA; Giralt M; Rubio D
Cancer; 1985 Nov; 56(10):2369-75. PubMed ID: 3899346
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of "CHOP" regimen in advanced untreated chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia.
Lancet; 1986 Jun; 1(8494):1346-9. PubMed ID: 2872470
[TBL] [Abstract][Full Text] [Related]
9. Chronic lymphocytic leukemia.
Rai KR; Sawitsky A; Jagathambal K; Gartenhaus W; Phillips E
Med Clin North Am; 1984 May; 68(3):697-711. PubMed ID: 6379339
[TBL] [Abstract][Full Text] [Related]
10. Is the CHOP regimen a good treatment for advanced CLL? Results from two randomized clinical trials. French Cooperative Group on Chronic Lymphocytic Leukemia.
Leuk Lymphoma; 1994 May; 13(5-6):449-56. PubMed ID: 8069190
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acute lymphoblastic leukemia in children with the BFM protocol: a cooperative study and analysis of prognostic factors.
Maurus R; Boilletot A; Otten J; Philippe N; Benoit Y; Behar C; Casteels-Van Daele M; Chantraine JM; Delbeke MJ; Gyselinck J
Haematol Blood Transfus; 1987; 30():466-70. PubMed ID: 3305214
[No Abstract] [Full Text] [Related]
12. [Therapy of non-Hodgkin's lymphoma].
Schaadt M; Plaumann L; Diehl V
Dtsch Med Wochenschr; 1984 Feb; 109(7):261-5. PubMed ID: 6199176
[No Abstract] [Full Text] [Related]
13. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
[TBL] [Abstract][Full Text] [Related]
14. Prognosis and therapy in hairy cell leukemia.
Jansen J; den Ottolander GJ; Holdrinet RS; Tricot GJ; Hermans J
Semin Oncol; 1984 Dec; 11(4 Suppl 2):472-8. PubMed ID: 6548834
[No Abstract] [Full Text] [Related]
15. Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
J Natl Cancer Inst; 1999 May; 91(10):861-8. PubMed ID: 10340906
[TBL] [Abstract][Full Text] [Related]
16. Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French Group.
Fière D; Archimbaud E; Extra JM; Marty M; David B; Witz F; Sotto JJ; Rochant H; Gastaut JA; Le Prise PY
Haematol Blood Transfus; 1987; 30():125-9. PubMed ID: 3305189
[TBL] [Abstract][Full Text] [Related]
17. [Present status of chemotherapy in ALL and CLL].
Ogawa M
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1882-7. PubMed ID: 6964032
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with the M-2 protocol (BCNU, cyclophosphamide, vincristine, melphalan, and prednisone) for chronic lymphocytic leukemia (stages III and IV).
Case DC; Porensky RS; Fanning JP
Oncology; 1985; 42(6):350-3. PubMed ID: 4069549
[TBL] [Abstract][Full Text] [Related]
19. Alternating pulses of vincristine-prednisone with cytarabine-cyclophosphamide versus vincristine-prednisone in the maintenance therapy of acute lymphoblastic leukemia.
Sackmann Muriel F; Svarch E; Pavlovsky S; Bustelo P; Giuntoli J; Vergara B; Garay G; Eppinger-Helft M; Kvicala R; Dibar E
Cancer Treat Rep; 1984 Apr; 68(4):581-6. PubMed ID: 6370428
[TBL] [Abstract][Full Text] [Related]
20. Therapy for adolescent and adult acute lymphoblastic leukemia: randomization of induction and consolidation therapies (preliminary results of EORTC Study 58791).
Stryckmans P; Marie JP; Suciu S; Solbu G; Debusscher L; Bury J; Peetermans M; Andrien JM; Fière D; Cauchie C
Haematol Blood Transfus; 1987; 30():130-6. PubMed ID: 3305190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
